OFTAMІRIN

Antimicrobial drug

learn more

OFTAMІRIN

Eye/ear/nasal drops

In the complex treatment of infectious processes in the anterior part of the eye (blepharitis, conjunctivitis, keratitis, keratouveitis) caused by gram-positive and gram-negative bacteria, chlamydia, fungi and viruses, sensitive to miramistin, eye trauma, eye burns (thermal and chemical).
Prevention of ophthalmia of newborns, including gonococcal and chlamydial.
Prevention and treatment of purulent-inflammatory lesions of the eyes in the pre- and postoperative period.
In the complex treatment of acute and chronic external otitis media, chronic purulent mesotympanitis, otomycosis.
In the complex treatment of acute rhinitis.

More in instructions (Ukrainian version)
INN
Miramistin
Package
0.1 mg/ml,1 x 0.1 mg/ml
Form of release
Drops
Appointment
Antimicrobial agents
АТС class
S03D, R01A

OFTAMІRIN

learn more

  • “Darnitsa” Defended its Right to its Product: Oftamirin Returning to the Shelves of Pharmacies

    In execution of the resolution of the Kyiv Commercial Court of Appeal dated 23 March 2017 in case No. 910/13320/13, the Ministry of Health of Ukraine cancelled its Order No. 410 dated 7 July 2015 and renewed the state registration of the medicinal product Oftamirin (marketing authorization  UA/12521/01/01) manufactured by the PrJSC “Pharmaceutical Firm “Darnitsa”, having included it to the State Register of Medicinal Products of Ukraine. Thus, the litigation was brought t

See also

See also

Specialized publications intended for medical institutions and doctors Limitations in obtaining information